Telehealth Usability, Engagement Patterns, and Technical Infrastructure in Managing Noncommunicable Diseases Among Health Care Professionals in Brazil, Ghana, Honduras, and the United Kingdom: Multinational Cross-Sectional Study - Top-Institutions - MDSpire

Telehealth Usability, Engagement Patterns, and Technical Infrastructure in Managing Noncommunicable Diseases Among Health Care Professionals in Brazil, Ghana, Honduras, and the United Kingdom: Multinational Cross-Sectional Study

  • By

  • Ken Brackstone

  • Roberta Lins Gonçalves

  • Adriana Silvina Pagano

  • Zilma Silveira Nogueira Reis

  • Seth Kwaku Afagbedzi

  • Lysien Ivania Zambrano

  • Tainá Costa Pereira Lopes

  • Sarah Almeida Cordeiro

  • Julia Macedo Nunes

  • Wagner Meira Jr

  • James Batchelor

  • Antonio Luiz Pinho Ribeiro

  • June 12, 2026

  • 0 min

Share

Top Institutions in Family Medicine

Brief introduction explaining scope and methodology.

  • #1

    London School of Hygiene & Tropical Medicine
    London School of Hygiene & Tropical Medicine

    London, United Kingdom

    Key Differentiators

    • Public Health
    • Global Health

  • #2

    Fundação Oswaldo Cruz (Fiocruz)
    Fundação Oswaldo Cruz (Fiocruz)

    Rio de Janeiro, Brazil

    Key Differentiators

    • Public Health
    • Epidemiology

Original Source(s)

Telehealth Usability, Engagement Patterns, and Technical Infrastructure in Managing Noncommunicable Diseases Among Health Care Professionals in Brazil, Ghana, Honduras, and the United Kingdom: Multinational Cross-Sectional Study

  • by Ken Brackstone, Roberta Lins Gonçalves, Adriana Silvina Pagano, Zilma Silveira Nogueira Reis, Seth Kwaku Afagbedzi, Lysien Ivania Zambrano, Tainá Costa Pereira Lopes, Sarah Almeida Cordeiro, Julia Macedo Nunes, Wagner Meira Jr, James Batchelor, Antonio Luiz Pinho Ribeiro

  • June 12, 2026

Related Content

ACP Suggests First-Line Obesity Drugs

Semaglutide and tirzepatide had the greatest net benefit among evaluated treatments, the committee concluded.

FDA Approval Targets Rare Kidney Disease

Phase 3 data showed greater proteinuria reduction vs irbesartan, with similar tolerability and a 1.1 mL/min/1.73 m² difference in estimated glomerular filtration rate at 108 weeks.

ApoB Goal Cost-Effective in Primary Prevention

Strategy increased quality-adjusted life-years and showed favorable cost-effectiveness vs low-density lipoprotein cholesterol and non–high-density lipoprotein cholesterol goals